A Single-Blind, Single-Treatment Study to Evaluate the Effects of Vildagliptin on Response to an Intravenous Glucose Load in Pre-Diabetic Subjects With Impaired Fasting Glucose.
Phase of Trial: Phase III
Latest Information Update: 04 May 2012
At a glance
- Drugs Vildagliptin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novartis
- 04 May 2012 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 21 Nov 2006 New trial record.